Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| STEP | STEPSTONE GROUP INC | $5.80B | 119,344,429 | 63.15% | 36.85% | Net Selling | Net Selling | ||
| SDRL | SEADRILL LTD | $2.66B | 62,530,508 | 99.56% | 0.44% | Net Selling | Net Selling | ||
| MLM | MARTIN MARIETTA MATERIALS INC | $33.39B | 60,065,839 | 78.89% | 21.11% | Net Selling | Net Buying | ||
| GMRS | GMR SOLUTIONS INC | $675.15M | 54,011,711 | 0.00% | 40.82% | Net Selling | Net Buying | ||
| MGTX | MEIRAGTX HOLDINGS PLC | $1.14B | 92,609,516 | 58.25% | 41.75% | Net Selling | Net Selling | ||
| PXED | PHOENIX EDUCATION PARTNERS INC | $1.06B | 36,047,376 | 31.63% | 68.37% | Net Selling | |||
| AVBP | ARRIVENT BIOPHARMA INC | $1.47B | 46,574,928 | 80.88% | 19.12% | Net Selling | |||
| APG | API GROUP CORP | $17.95B | 432,160,297 | 80.57% | 18.65% | Net Selling | Net Selling | ||
| WVE | WAVE LIFE SCIENCES LTD | $1.18B | 197,048,175 | 77.32% | 22.68% | Net Buying | |||
| PICS | PICS NV | $1.40B | 106,730,400 | 13.99% | 5.26% | Net Buying | Net Buying | ||
| AMLX | AMYLYX PHARMACEUTICALS INC | $2.43B | 111,186,317 | 67.16% | 32.84% | Net Selling | Net Selling | ||
| GUTS | FRACTYL HEALTH INC | $108.67M | 158,648,963 | 45.39% | 18.44% | Net Buying | Net Buying | ||
| EQT | EQT CORP | $33.01B | 625,516,000 | 88.26% | 11.74% | Net Selling | Net Selling | ||
| MDLN | MEDLINE INC | $55.23B | 1,313,688,164 | 33.59% | 66.41% | Net Selling | Net Selling | ||
| MIDD | MIDDLEBY CORP | $6.27B | 45,214,496 | 89.50% | 10.50% | Net Buying | |||
| SUJA | SUJA LIFE INC | $271.19M | 23,788,700 | 0.00% | 72.92% | ||||
| SGHT | SIGHT SCIENCES INC | $306.87M | 54,409,942 | 41.40% | 57.22% | Net Selling | Net Selling | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.65B | 171,235,870 | 71.81% | 28.19% | Net Selling | Net Selling | ||
| DEC | DIVERSIFIED ENERGY CO | $969.13M | 72,323,471 | 68.93% | 13.03% | Net Selling | |||
| BRZE | BRAZE INC | $2.97B | 112,631,669 | 46.80% | 53.20% | Net Selling | Net Selling | ||
| LBRT | LIBERTY ENERGY INC | $3.23B | 163,191,416 | 66.30% | 33.70% | Net Selling | Net Selling | ||
| MEC | MAYVILLE ENGINEERING COMPANY INC | $568.30M | 20,494,006 | 70.08% | 9.23% | Net Selling | Net Selling | ||
| PTCT | PTC THERAPEUTICS INC | $5.77B | 83,460,802 | 86.87% | 13.13% | Net Selling | Net Selling | ||
| INFQ | INFLEQTION INC | $2.50B | 218,196,891 | 28.48% | 9.23% | Net Selling | Net Selling | ||
| STVN | STEVANATO GROUP SPA | $5.95B | 302,842,536 | 14.71% | 83.89% | Net Selling | Net Selling | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $44.42M | 22,662,943 | 33.55% | 66.45% | Net Selling | Net Selling | ||
| EVER | EVERQUOTE INC | $844.01M | 35,373,278 | 61.67% | 38.33% | Net Selling | Net Selling | ||
| BTGO | BITGO HOLDINGS INC | $577.48M | 115,959,409 | 30.56% | 12.79% | Net Selling | Net Selling | ||
| CLSK | CLEANSPARK INC | $3.64B | 256,608,606 | 76.99% | 23.01% | Net Selling | Net Selling | ||
| RLMD | RELMADA THERAPEUTICS INC | $573.75M | 104,890,223 | 79.76% | 3.37% | Net Buying | |||
| CSTL | CASTLE BIOSCIENCES INC | $952.53M | 30,549,507 | 85.17% | 14.83% | Net Selling | Net Selling | ||
| IBIO | IBIO INC | $72.53M | 49,678,561 | 35.96% | 64.04% | Net Buying | |||
| GENB | GENERATE BIOMEDICINES INC | $1.83B | 128,192,484 | 57.21% | 42.79% | Net Buying | |||
| ABVX | ABIVAX SA | $9.88B | 78,958,563 | 63.37% | 0.00% | ||||
| TYRA | TYRA BIOSCIENCES INC | $1.93B | 59,470,381 | 65.84% | 34.16% | Net Selling | |||
| MDXH | MDXHEALTH SA | $2.27M | 51,364,520 | 40.85% | 59.15% | ||||
| AKTS | AKTIS ONCOLOGY INC | $1.22B | 53,404,618 | 52.35% | 47.65% | Net Buying | Net Buying | ||
| SPRB | SPRUCE BIOSCIENCES INC | $127.32M | 2,752,278 | 3.89% | 96.11% | Net Selling | Net Buying | ||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $176.79M | 28,423,069 | 85.46% | 12.98% | Net Buying | |||
| KEEL | KEEL INFRASTRUCTURE CORP | $2.48B | 603,828,651 | 42.26% | 0.36% | Net Selling | Net Selling | ||
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $710.55M | 80,107,104 | 62.76% | 37.24% | Net Buying | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $848.64M | 98,449,606 | 60.22% | 39.78% | Net Selling | |||
| SPTX | SEAPORT THERAPEUTICS INC | $1.15B | 53,530,550 | 0.00% | 74.84% | Net Buying | Net Buying | ||
| EROC | EROCK INC | N/A | 48,124,888 | 0.00% | 100.00% | ||||
| FDX | FEDEX CORP | $74.13B | 236,581,188 | 79.13% | 9.64% | Net Buying | Net Buying | ||
| CX | CEMEX SAB DE CV | $16.84B | 14,507,429,244 | 3.51% | 1.82% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $1.08B | 61,458,046 | 57.24% | 42.76% | Net Buying | Net Buying | ||
| KGC | KINROSS GOLD CORP | $28.00B | 1,186,240,789 | 60.40% | 0.00% | ||||
| CATX | PERSPECTIVE THERAPEUTICS INC | $342.14M | 114,046,197 | 41.47% | 58.53% | Net Buying | |||
| PAAS | PAN AMERICAN SILVER CORP | $18.93B | 421,424,000 | 51.40% | 0.00% | ||||
| ZLAB | ZAI LAB LTD | $2.08B | 1,123,548,580 | 2.51% | 1.78% | Net Buying | Net Buying | ||
| ONC | BEONE MEDICINES LTD | $35.95B | 1,445,262,342 | 2.41% | 31.88% | Net Selling | Net Selling | ||
| KLRA | KAILERA THERAPEUTICS INC | $2.35B | 129,565,608 | 0.00% | 85.31% | Net Buying | Net Buying | ||
| PPTA | PERPETUA RESOURCES CORP | $2.59B | 125,094,503 | 59.66% | 40.34% | Net Selling | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.03B | 87,347,471 | 79.99% | 20.01% | Net Selling | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $990.70M | 35,093,940 | 76.45% | 18.01% | Net Selling | |||
| CTMX | CYTOMX THERAPEUTICS INC | $722.77M | 217,702,919 | 88.73% | 10.06% | Net Selling | Net Selling | ||
| ODTX | ODYSSEY THERAPEUTICS INC | $958.71M | 48,031,320 | 0.00% | 25.85% | Net Buying | Net Buying | ||
| DNLI | DENALI THERAPEUTICS INC | $3.84B | 158,709,737 | 62.37% | 37.63% | Net Selling | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $273.61M | 24,716,672 | 47.68% | 52.32% | Net Buying | Net Buying | ||
| ZBIO | ZENAS BIOPHARMA INC | $1.98B | 63,133,377 | 74.49% | 25.51% | Net Buying | Net Buying | ||
| NYXH | NYXOAH SA | $62.39M | 43,026,460 | 8.36% | 0.00% | ||||
| CLYM | CLIMB BIO INC | $719.19M | 57,260,523 | 56.39% | 11.04% | Net Buying | Net Selling | ||
| ONIT | ONITY GROUP INC | $321.35M | 8,432,137 | 3.18% | 96.82% | Net Selling | Net Selling | ||
| TFPM | TRIPLE FLAG PRECIOUS METALS CORP | $6.18B | 206,603,912 | 84.74% | 0.00% | ||||
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $2.16T | 25,932,370,000 | 2.97% | 6.68% | Net Selling | Net Selling | ||
| VKTX | VIKING THERAPEUTICS INC | $3.84B | 116,652,937 | 62.74% | 8.90% | Net Selling | Net Selling | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.36B | 84,479,418 | 42.06% | 57.94% | Net Selling | Net Selling | ||
| IDYA | IDEAYA BIOSCIENCES INC | $3.17B | 87,860,920 | 92.57% | 7.43% | Net Buying | Net Buying | ||
| XNDU | XANADU QUANTUM TECHNOLOGIES LTD | $3.46B | 298,511,364 | 6.66% | 0.27% | ||||
| ALLO | ALLOGENE THERAPEUTICS INC | $655.79M | 345,154,561 | 53.35% | 22.59% | Net Selling | |||
| MANE | VERADERMICS INC | $4.48B | 41,778,687 | 62.15% | 15.06% | Net Buying | |||
| OFIX | ORTHOFIX MEDICAL INC | $493.14M | 40,421,652 | 70.58% | 29.42% | Net Buying | Net Selling | ||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $255.69M | 59,880,715 | 36.71% | 63.29% | Net Selling | Net Selling | ||
| CING | CINGULATE INC | $65.05M | 13,276,022 | 8.95% | 32.96% | Net Buying | |||
| TRVI | TREVI THERAPEUTICS INC | $2.66B | 141,979,708 | 43.91% | 56.09% | Net Buying | |||
| TTAN | SERVICETITAN INC | $8.23B | 95,397,579 | 47.66% | 52.34% | Net Selling | Net Selling | ||
| ANL | ADLAI NORTYE LTD | $519.48M | 120,000,803 | 9.66% | 14.54% | Net Selling | Net Selling | ||
| PTEN | PATTERSON UTI ENERGY INC | $3.83B | 379,617,653 | 83.60% | 16.40% | Net Selling | Net Selling | ||
| EVEX | EVE HOLDING INC | $996.15M | 348,304,584 | 5.13% | 94.87% | Net Buying | |||
| CADL | CANDEL THERAPEUTICS INC | $770.07M | 73,270,239 | 59.27% | 24.02% | Net Buying | Net Selling | ||
| WHK | WHITEHAWK MINERALS CORP | N/A | 25,971,579 | 0.00% | 27.29% | ||||
| MDA | MDA SPACE LTD | $4.33B | 126,321,001 | 64.23% | 0.00% | ||||
| CAN | CANAAN INC | $138.12M | 10,358,912,865 | 1.40% | 3.58% | ||||
| B | BARRICK MINING CORP | $64.04B | 1,676,000,000 | 61.92% | 0.00% | ||||
| KARD | KARDIGAN INC | N/A | 87,672,455 | 0.00% | 76.75% | Net Buying | Net Buying | ||
| BKR | BAKER HUGHES CO | $61.28B | 992,674,071 | 92.33% | 0.67% | Net Selling | Net Selling | ||
| BKV | BKV CORP | $2.55B | 109,386,611 | 35.23% | 64.77% | Net Selling | Net Selling | ||
| TENX | TENAX THERAPEUTICS INC | $517.20M | 37,423,917 | 57.43% | 21.42% | Net Buying | Net Buying | ||
| EXE | EXPAND ENERGY CORP | $21.55B | 231,503,789 | 90.19% | 9.81% | Net Buying | Net Buying | ||
| TBN | TAMBORAN RESOURCES CORP | $916.97M | 28,318,909 | 30.43% | 37.70% | Net Buying | |||
| DTIL | PRECISION BIOSCIENCES INC | $187.84M | 25,802,247 | 36.70% | 63.30% | Net Selling | |||
| NG | NOVAGOLD RESOURCES INC | $2.78B | 438,780,614 | 61.11% | 38.89% | Net Buying | Net Buying | ||
| NNE | NANO NUCLEAR ENERGY INC | $946.35M | 52,083,294 | 39.79% | 60.21% | Net Selling | Net Selling | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.86B | 305,375,393 | 40.70% | 44.12% | Net Buying | Net Buying | ||
| NSLR | NEOSTELLAR CAPITAL CORP | $290.68M | 26,070,208 | 20.57% | 16.91% | Net Selling | Net Selling | ||
| BEAT | HEARTBEAM INC | $27.59M | 55,506,835 | 9.27% | 19.39% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $121.69M | 8,967,693 | 18.36% | 81.64% | Net Buying | |||
| GLXY | GALAXY DIGITAL INC | $8.63B | 389,900,100 | 33.54% | 1.50% | Net Selling | Net Selling | ||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.32B | 73,615,396 | 77.11% | 22.89% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.